Social Disconnection Study
Yale University · with National Institute of Mental Health (NIMH) · NCT06705348
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 55+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- May 8, 2023
- Record last updated
- August 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research study is to examine the effect of social connectedness on the brain. Study procedures include one Magnetic Resonance Imaging (MRI) or functional Magnetic Resonance Imaging (fMRI) scan, one Positron Emission Tomography (PET) scan, one Magnetic Resonance Spectroscopy (MRS) scan, an electroencephalogram (EEG), and in-person and phone call follow-ups.
Conditions: Social Disconnection
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- able to give written informed consent
- age 55+
- English speaking
Exclusion Criteria
- contraindication to MRI scanning including claustrophobia, high girth, moderate to significant white matter atrophy, and presence of ferromagnetic material in the body, including orthodontic braces or other non MR-compatible foreign bodies. All participants will be screened for metal objects by the same methods used for routine clinical MRI scanning
- for women: pregnancy or breastfeeding
- serious medical or neurological illness that in the opinion of the PI would interfere with the scientific goals of the study or participant safety
- pervasive developmental disorders (PDD) or primary psychotic disorders
- meet DSM-5 criteria for current severe substance use disorder (except marijuana or nicotine)
- head injury that led to significant long term decline in cognitive abilities as seen by decline in grades or work performance
- current psychosis, active significant suicidal (score of 6 on MADRS suicide item) or homicidal ideation
- lifetime history of neurologic abnormality including seizure disorder, cerebrovascular, or neoplastic lesion, neurodegenerative disorder, or significant head trauma resulting in post-traumatic amnesia >24 hours
- full scale IQ lower than 70
- contraindications to PET (e.g. poor venous access for placement of venous lines)
- history of prior radiation exposure for research purposes within the past year such that participation in this study would place them over FDA limits for annual radiation exposure. This guideline is an effective dose of 5 rem received per year
- history of a bleeding disorder or currently taking anticoagulants (such as Coumadin, Heparin, Pradaxa, Xarelto) *for subjects obtaining arterial line.
- blood donation within 8 weeks of the start of the study
- REM sleep disorder
- brain injury (TBI, seizure/epilepsy, stroke, TIA) in lifetime (self-report and medical chart review)
- electroconvulsive or ketamine therapy, or similar therapies that have rapid effects on brain neurochemistry within the past 6 months
- high risk for stroke (above first quartile on Framingham Stroke Risk Profile)
- current cancer
Recruiting US locations
Yale Translational Brain Imaging Program
New Haven, CT 06510
Site contact: Sarah Boster, MA · 203-737-7066 · sarah.debonee@yale.edu
Study contacts (from the official record)
- Sarah Boster, MA · 203-737-7066 · Sarah.debonee@yale.edu
- Nicole DellaGioia, MA · 203-737-6884 · nicole.dellagioia@yale.edu
Similar studies in Connecticut
All healthy volunteers studies in Connecticut →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Pfizer
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1Overnight stay mentioned
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 21–70
- RecruitingHealthy volunteersPhase 1
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)
XingImaging, LLC
- Location
- New Haven, CT
- Eligibility basics
- Ages 40–80
- RecruitingHealthy volunteersEarly Phase 1
A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers
Ratio Therapeutics, Inc.
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–60